日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification of the LCOR-PLCL1 pathway that restrains lipid accumulation and tumor progression in clear cell renal cell carcinoma.

鉴定出抑制透明细胞肾细胞癌中脂质积累和肿瘤进展的 LCOR-PLCL1 通路

Li Wen, Shi Jian, Lv Qingyang, Miao Daojia, Tan Diaoyi, Lu Xiaojun, Xiong Hairong, Luo Qianqian, Xia Yaru, Han Yuqi, Dong Xuejiao, Huang Guixiao, Zhang Xiaoping, Yang Hongmei

PUMA reduces FASN ubiquitination to promote lipid accumulation and tumor progression in human clear cell renal cell carcinoma.

PUMA 可降低 FASN 泛素化,从而促进人类透明细胞肾细胞癌中的脂质积累和肿瘤进展

Luo Qianqian, Wang Qi, Shi Jian, Lv Qingyang, Dong Zirui, Li Wen, Xia Yaru, Liu Jingchong, Yang Hongmei

Emerging roles of metabolic biomarkers in renal cell carcinoma: from molecular mechanisms to clinical implications

代谢生物标志物在肾细胞癌中的新兴作用:从分子机制到临床意义

Yang, Junkai; Miao, Daojia; Li, Xinwei; Zhao, Chuanyi; Tan, Diaoyi; Wu, Songming; Lu, Feiyi; Shi, Jian; Lv, Qingyang; Ruan, Hailong; Xiong, Zhiyong; Zhang, Xiaoping

Publisher Correction: N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway

出版商更正:N6-甲基腺苷修饰的ALDH9A1通过NPM1/IQGAP2/AKT信号通路调节透明细胞肾细胞癌中的脂质积累和肿瘤进展。

Tan, Diaoyi; Miao, Daojia; Zhao, Chuanyi; Shi, Jian; Lv, Qingyang; Lu, Feiyi; Ruan, Hailong; Xiong, Zhiyong; Zhang, Xiaoping

Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma

对A12代谢相关基因特征及其与透明细胞肾细胞癌肿瘤转移关系的综合分析

Tan, Diaoyi; Miao, Daojia; Zhao, Chuanyi; Shi, Jian; Lv, Qingyang; Xiong, Zhiyong; Yang, Hongmei; Zhang, Xiaoping

The Downregulation of Prognosis- and Immune Infiltration-Related Gene CYFIP2 Serves as a Novel Target in ccRCC

预后及免疫浸润相关基因CYFIP2的下调是透明细胞肾细胞癌(ccRCC)的新靶点

Tong, Junwei; Meng, Xiangui; Lv, Qingyang; Yuan, Hongwei; Li, Weiquan; Xiao, Wen; Zhang, Xiaoping

Genetic alteration and clinical significance of SUMOylation regulators in multiple cancer types

SUMO化调节因子的基因改变及其在多种癌症类型中的临床意义

Wu, Guangzhen; Xu, Yingkun; Ruan, Ningke; Li, Jianyi; Lv, Qingyang; Zhang, Qi; Chen, Yougen; Wang, Qifei; Xia, Qinghua; Li, Quanlin